Tvardi Therapeutics Inc.

NASDAQ: TVRD · Real-Time Price · USD
24.30
0.51 (2.14%)
At close: Aug 15, 2025, 3:59 PM
24.00
-1.23%
After-hours: Aug 15, 2025, 04:10 PM EDT

Tvardi Therapeutics Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Revenue
7.57M 7.14M 5.68M 7.99M 7M 4.87M 4.87M
Cost of Revenue
150K 770K 770K 2.31M 2.24M 1.62M 1.62M
Gross Profit
5.97M 4.91M 4.91M 5.68M 4.76M 3.25M 3.25M
Operating Income
-30.9M -58.18M -56.84M -79.44M -63.23M -33.56M -28.9M
Interest Income
1.88M 1.88M 1.77M 1.87M 1.18M 1.18M 866K
Pretax Income
-45.48M -71.27M -67.54M -83.09M -63.08M -32.38M -28.03M
Net Income
-45.08M -70.87M -67.54M -83.09M -63.08M -32.38M -28.03M
Selling & General & Admin
24.24M 26.39M 20.24M 20.56M 14.19M 7.41M 6.72M
Research & Development
11.12M 32.77M 36.58M 60.64M 51.37M 29.41M 25.42M
Other Expenses
2.96M 5.39M 4.94M 3.92M 2.43M n/a n/a
Operating Expenses
38.32M 64.55M 61.76M 85.12M 67.99M 36.81M 32.15M
Interest Expense
9.36M 8.47M 5.85M 3.89M 1.98M n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
38.47M 65.32M 62.53M 87.43M 70.23M 38.43M 33.76M
Income Tax Expense
-398K -398K n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
Shares Outstanding (Diluted)
9.36M 1.52M 1.52M 1.52M 9.36M 9.36M 1.51M
EPS (Basic)
-26.92 -29.68 -25.1 -35.52 -22.35 -19.07 -18.61
EPS (Diluted)
-26.92 -29.68 -25.1 -35.52 -22.35 -19.07 -18.61
EBITDA
-35.97M -62.6M -60.47M -77.53M -59.51M -30.83M -27.51M
EBIT
-36.12M -62.79M -60.68M -78.2M -60.09M -31.38M -28.03M
Depreciation & Amortization
150K 192K 216K 664K 587K 545K 521K